• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Hua Han Bio-Pharmaceutical Holdings Ltd

+ Add to Watchlist


0.201 EUR 0.019 8.64%

As of 04:55:03 ET on 01/27/2015.

Snapshot for Hua Han Bio-Pharmaceutical Holdings Ltd (HUI)

Open: 0.217 Day's Range: 0.201 - 0.217 Volume: 0
Previous Close: 0.220 52wk Range: 0.097 - 0.257 1-Yr Rtn: +72.19%

Stock Chart for HUI

No chart data available.
  • HUI:GR 0.201
  • 1D
  • 1M
  • 1Y
Interactive HUI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HUI

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) 17.6902
Relative P/E vs. DAX -
Earnings Per Share (HKD) (ttm) -
Est. EPS (HKD) (06/2015) 0.1000
Est. PEG Ratio -
Market Cap (M EUR) 987.85
Shares Outstanding (M) 4,914.69
30 Day Average Volume 480
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.60%
Cash Dividend (HKD) 0.0300
Dividend Ex-Date 01/02/2015
5 Year Dividend Growth 26.60%
Next Earnings Announcement 02/23/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HUI

  • Revenue
  • Net Income (M/HKD)
  • Profit Margin (%)

Company Profile & Key Executives for HUI

Hua Han Bio-Pharmaceutical Holdings Limited, through its subsidiaries, researches, develops, manufactures, and sells Chinese herbal pharmaceutical products primarily for women and the elderly under its Yeosure brand name. The Company also researches, develops, manufactures, and sells naturally-sourced anti-tumor medicines and western pharmaceutical products.

Zhang Peter YChairman/Co-FounderDeng JieCEO/Co-Founder
Zhang Bing ShengChief Investment SupervisorNiu YiChief Inspector:Human Resource
More Company Profile & Key Executives for HUI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil